Generics - Genito-urinary, Patents

Filter

Current filters:

Genito-urinaryPatents

Popular Filters

Watson confirms Lumigan and Latisse patent challenges; favorable Sanctura ruling

05-04-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories,…

AllerganGenericsGenito-urinaryLatisseLegalLumiganOphthalmicsPatentsSanctura XRWatson Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top